Mechanistic comparison of Methylnitronitrosoguanidine and alyssin [Supplementary Concept] based on molecular target overlap from BindingDB and ChEMBL binding affinity data.
3
Shared Targets
16%
Jaccard Similarity
12%
IDF-Weighted Similarity
Jaccard measures raw target overlap. IDF-weighted downweights promiscuous hub targets (e.g. CYP enzymes) that bind many compounds non-specifically.
Methylnitronitrosoguanidine and alyssin share 3 molecular targets based on binding affinity data from BindingDB (Kd/IC50 ≤ 10 µM) and ChEMBL. A Jaccard index of 0.158 means 16% of the combined target set is bound by both compounds. The IDF-weighted score of 0.117 accounts for non-specific binding to metabolic enzymes.
Note: High target overlap does not imply identical mechanism or therapeutic equivalence. Binding affinity, tissue distribution, bioavailability, and downstream signaling differ significantly between compounds even when they bind the same protein.
Frequently Asked Questions
What do Methylnitronitrosoguanidine and alyssin have in common?
Methylnitronitrosoguanidine and alyssin share 3 molecular targets with a Jaccard similarity of 16%. Both bind overlapping sets of proteins based on BindingDB and ChEMBL binding affinity data.
Can Methylnitronitrosoguanidine and alyssin be combined?
Methylnitronitrosoguanidine and alyssin share 3 molecular targets, suggesting potential pathway overlap. Combination use should be evaluated with a qualified healthcare professional. BiohacksAI does not provide medical advice.
Which has more research: Methylnitronitrosoguanidine or alyssin?
Both Methylnitronitrosoguanidine and alyssin have substantial PubMed research. View their individual profiles for full evidence scores.